Vreni Foertsch

Title: Vreni Foertsch: Innovator in Protein Purification

Introduction

Vreni Foertsch is a notable inventor based in Winznau, Switzerland. She has made significant contributions to the field of protein purification, holding three patents to her name. Her work focuses on the separation and purification of important proteins that have pharmaceutical applications.

Latest Patents

One of her latest patents involves methods for the purification of alpha-1-antitrypsin (AAT) and apolipoprotein A-I (ApoA-1). This invention relates to protein separation and purification methods for both AAT and ApoA-1 from human blood plasma. The invention provides methods for separating AAT from ApoA-1 at the initial stage of purification, allowing the same starting material to be used as a source for both proteins. Furthermore, the methods pertain to providing compositions of AAT and ApoA-1 that are suitable for pharmaceutical use and large-scale purification.

Career Highlights

Vreni Foertsch is currently employed at CSL Behring GmbH, a company known for its focus on biopharmaceuticals. Her work at CSL Behring has allowed her to apply her innovative methods in a practical setting, contributing to advancements in the treatment of various medical conditions.

Collaborations

Throughout her career, Vreni has collaborated with notable colleagues, including Nathan Brinkman and Douglas Bigler. These collaborations have further enhanced her research and development efforts in the field of protein purification.

Conclusion

Vreni Foertsch is a pioneering inventor whose work in protein purification has significant implications for pharmaceutical applications. Her innovative methods and collaborations continue to advance the field, making her a key figure in biopharmaceutical research.